Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MDFIC - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLTP - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RFX4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DNALI1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EFEMP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
BBOX1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PLSCR4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TPD52L1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GNG12 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GOLIM4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MYO5C - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
AHCYL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
STON2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
OGFRL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FSTL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC39A12 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
WWC1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SPAG1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RNF19A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on